Pulse biosciences, inc. (PLSE)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15
Revenue

-

-

-

-

0

Operating expenses:
General and administrative

22,327

20,045

15,503

3,415

1,621

Research and development

24,961

17,253

9,646

5,506

2,181

Amortization of intangible assets

666

665

665

665

666

Total operating expenses

47,954

37,963

25,814

9,586

4,468

Other income:
Interest income

983

446

247

68

-

Other

-

28

-

-

-

Total other income

983

418

247

68

-

Loss from operations, before income taxes

-46,971

-37,545

-25,567

-9,518

-4,468

Income tax benefit

-

-

-

-

-1,657

Net loss

-46,971

-37,545

-25,567

-9,518

-2,811

Other comprehensive loss:
Unrealized gain on available-for-sale securities

5

50

-44

-7

-

Comprehensive loss

-46,966

-37,495

-25,611

-9,525

-2,811

Net loss per share:
Basic and diluted net loss per share

-2.26

-2.20

-1.73

-0.86

-0.37

Weighted average shares used to compute net loss per common share - basic and diluted

20,746

17,078

14,754

11,009

7,565